Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2004-05-14
2008-09-09
Foley, Shanon A. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C435S069100, C435S069700, C435S252300, C530S300000, C530S350000, C424S249100, C424S190100, C424S184100, C536S023100, C536S023700
Reexamination Certificate
active
07422754
ABSTRACT:
The invention provides novelNeisseria meningitides(Nm) polypeptides and polynucleotides which cover the Nm genetic diversity, and which correspond to polypeptide of Nm outer membrane and/or periplasma, and to methods for producing such Nm compounds. Also provided are anti-Nm infection, and particularly diagnostic. prophylactic and therapeutic uses thereof.
REFERENCES:
patent: WO 90 04641 (1990-05-01), None
patent: WO 90 06696 (1990-06-01), None
patent: WO 92 03467 (1992-03-01), None
patent: WO 94 05326 (1994-03-01), None
patent: WO 97 28273 (1997-08-01), None
Bowie et al (Science, 1990, 257:1306-1310); Roitt et al (Immunology, 1993, Mosby, St. Louis, p. 7.7-7.8.
Herbert et al (The Dictionary of Immunology, Academic Press, 3rd Edition, London, 1985, pp. 58-59).
Accession: B81989 Parkhill Nature 404, 502-506, 2000.
Holmes (Exp. Opin.Invest. Drugs, 2001, 10(3):511-519).
Nassif et al, “What do we know about the entry ofNeisseria meningitidisinto the meninges?”, Bull. Ins. Pasteur, vol. 95, No. 4, 1997, pp. 219-235.
Ala'Aldeen, “Vaccines AgainstNeisseria meningitidis: Past, Present and Future”, Biotecnologia Aplicada, vol. 13, No. 1, 1996, pp. 1-7.
Gomez et al, “Antigenicity, cross-reactivity and surface exposure of theNeisseria meningitidis37 kDa protein (Fbp)”, Vaccine, vol. 14, No. 14, 1996, pp. 1340-1346.
Sarkari et al, “Variable expression of the Opc outer membrane protein inNeisseria meningitidisis caused by size variation of a promoter containing poly-citidine”, Molecular Microbiology, vol. 13, No. 2, 1994, pp. 207-217.
Maiden et al, “Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms” Proc. Natl. Acad. Sci. USA, vol. 95, Mar. 1998, pp. 3140-3145.
Watarai et al, “Disulfide oxidoreductase activity ofShigella flexneriis required for release of Ipa proteins and invasion of epithelial cells”, Proc. Natl. Acad. Sci. U.S.A., vol. 92, 1995, pp. 4927-4931.
Peek et al, “Characterization of a periplasmic thiol:disulfide interchange protein required for the functional maturation of secreted virulence factors ofVibrio chlorae”, Proc. Natl. Acad. Sci. U.S.A., vol. 89, 1992, pp. 6210-6214.
Jonson et al, “Cloning and sequencing ofVibrio choleramannose-sensitive haemagglutinin pilin gene: localization of mshA within a cluster of type 4 pilin genes”, Molecular Microbiology, vol. 13, No. 1, 1994, pp. 109-118.
Van der Ley et al, “Construction ofNeisseria meningitidisstrains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane vesicle vaccine”, Vaccine, vol. 13, No. 4, 1995, pp. 401-407.
Scheuerpflug et al, “Roles of PilC and PilE proteins in pilus-mediated adherence ofNeisseria gonorrhoeaandNeisseria meningitidisto human erythrocytes and endothelial and epithelial cells”, Infection and Immunity, vol. 67, No. 2, Feb. 1999, pp. 834-843.
Stibitz et al, “Genetic analysis of a region of theBordetella pertussischromosome encoding filamentous hemagglutinen and the pleiotropic regulatory locus vir”, Journal of Bacteriology, vol. 170, No. 7, Jul. 1988, pp. 2904-2913.
Virji et al, “Variations in the expression of pili: the effect on adherence ofNeisseria meningitidisto human epithelial and endothelial cells”, Molecular Microbiology, GB, Oxford, vol. 6, No. 10, 1992, pp. 1271-1279.
Zhou et al, “Sequence diversity within the argF, fbp and recA genes of natural isolates ofNeisseria meningitidis: interspecies recombination within the argF gene”, Molecular Microbiology, vol. 6, No. 15, 1992, pp. 2135-2146.
Barenkamp et al, “Cloning, Expression, and DNA Sequence Analysis of Genes Encoding NontypeableHaemophilus influenzaeHigh-Molecular-Weight Surface-Exposed Proteins Related to Filamentous Hemagglutinin ofBordetella pertussis”, Inflection and Immunity, US, American Society for Microbiology, Washington, vol. 60, No. 4, Apr. 1, 1992, pp. 1302-1313.
Salit et al, “Adherence ofNeisseria meningitidisto human epithelial cells”, Infection and Immunity, vol. 31, No. 1, Jan. 1981, pp. 430-435.
EMBL databases; Heidelberg, Germany, May 18, 1999, “Neisseria meningitidisNatD (natD) and NatC (natC) genes, complete cds.”, abstract.
Stone et al, “Salmonella enteritidishas a homologue of tolC that is required for virulence in BALB/c mice”, Molecular Microbiology, vol. 17, No. 4, 1995, pp. 701-712.
Achtman Mark
Klee Silke
Merker Petra
Nassif Xavier
Tinsley Colin
Baskar Padma v
Foley Shanon A.
Institut National de la Sante et de la Recherche Medicale (Inser
Max-Planck Gesellschaft zur Forderung des Wissenschaften E.V.
Nixon & Vanderhye P.C.
LandOfFree
Neisseria meningitidis compounds and anti-infection... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neisseria meningitidis compounds and anti-infection..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neisseria meningitidis compounds and anti-infection... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3965914